The startup employs AI algorithms to analyze genetic data for identifying mutations associated with hereditary diseases. This technology enables healthcare providers to deliver accurate diagnoses and tailored treatment plans for patients with genetic disorders.
Funding
$5.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ACCSCDEFFounders
Product
Problem
The interpretation of genetic variants from DNA sequencing is a significant bottleneck in diagnosing rare genetic diseases, often delaying accurate diagnoses and tailored treatment plans for patients. Existing methods can be laborious, costly, and yield inconclusive results, leaving a substantial percentage of individuals without a clear diagnosis.
Solution
Nostos Genomics offers an AI-driven variant interpretation platform, AION, designed to automate and accelerate the identification of pathogenic variants. AION leverages machine learning and a comprehensive database of genomic annotations to provide accurate decision support, improving diagnostic yield compared to traditional rules-based methods. The platform delivers variant interpretations in under two minutes and generates comprehensive reports automatically. By providing insights into how and why variants are classified and prioritized, AION ensures AI predictions are verifiable by human experts.
Target Audience
The primary target audience includes genetic testing labs and clinical researchers focused on rare disease diagnostics, seeking to scale their genomic sequencing operations and provide faster, more accurate insights to patients.
Features
- AI-driven platform for automated variant interpretation
- Rapid analysis, providing interpretations for exomes in under 2 minutes
- White-box approach, offering insights into variant classification and prioritization
- Improves diagnostic yield by over 50% compared to rules-based ACMG classification
- Regularly updated database containing over 100 annotations
- Seamless integration with existing databases and APIs
- CE-IVDR certified, ensuring compliance with European regulations for in-vitro diagnostics